X-trodes, a Tel Aviv, Israel-based bio-convergence company that developed wearable technology for advanced electrophysiological measurement and analytics, raised $4.5m in seed funding.
The round was led by Japan Israel High Tech Ventures (Chartered Group), Welltech. and Jeremy Coller.
Led by Ziv Peremen, co-founder and CEO, X-trodes is a bio-convergence company and the developer of the world’s first scalable wireless Smart Skin- a wearable technology for advanced electrophysiological monitoring and analytics, that can be used by patients in their natural environment.
The two first products that X-trodes brings to market are:
- Medical-grade sleep monitoring- a wireless system for sleep monitoring, especially for neurological and psychiatric disorders. X-trodes single patch for multi-modality measurement, retrieves meaningful insights and diagnostics from patients’ own bed, in their natural environment.
- Muscle recovery – A flexible wearable system that prevents muscle injuries and accelerates recovery by monitoring electrophysiology function in dynamic environments and analysing every muscle with wireless AI-driven insights.
The company has 12 employees.
FinSMEs
18/10/2021